Related Experiment Video
Updated: Nov 23, 2025
12:56
Methodology for Biomimetic Chemical Neuromodulation of Rat Retinas with the Neurotransmitter Glutamate In Vitro
Published on: December 19, 2017
8.0K
Optogenetic Strategies for Vision Restoration.
1Department of Ophthalmology, Visual and Anatomical Sciences, Wayne State University School of Medicine, Detroit, MI, USA.
Advances in Experimental Medicine and Biology
|January 5, 2021
Summary
Optogenetic therapy uses microbial channelrhodopsins (ChRs) to restore vision by making inner retinal neurons light-sensitive. This approach is advancing to clinical trials for treating blindness caused by photoreceptor loss.
Area of Science:
- Neuroscience
- Ophthalmology
- Biotechnology
Background:
- Retinal degenerative diseases cause photoreceptor cell loss, leading to blindness.
- Optogenetics offers a potential strategy to restore vision by re-sensitizing the retina to light.
Purpose of the Study:
- To review early proof-of-concept studies on optogenetic vision restoration.
- To discuss the development of improved channelrhodopsin (ChR) tools.
- To explore the restoration of intrinsic visual processing in retinas with photoreceptor degeneration.
Main Methods:
- Expressing channelrhodopsin-2 (ChR2) in retinal ganglion cells of blind mice.
- Utilizing various microbial channelrhodopsins (ChRs) for optogenetic manipulation.
- Developing enhanced ChR tools for improved efficacy.
Main Results:
- Demonstrated the feasibility of optogenetic vision restoration.
- Showcased the advancement of ChR-based therapies to clinical trials.
- Investigated methods to restore visual processing in degenerated retinas.
Conclusions:
- Optogenetic approaches hold significant promise for treating blindness.
- Ongoing research focuses on refining ChR tools and visual processing restoration.
- ChR-based therapies are progressing towards clinical application for vision restoration.
